1. Targeting the target of rapamycin (TOR): looking to mother nature

   • Eric K. Rowinsky

   Editorial 27 April 2011 Pages: 1 - 4

2. Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

   • Sumanta Kumar Pal
   • Robert A. Figlin

   Review 12 April 2011 Pages: 5 - 16

   

3. Mechanisms of mTOR inhibitor resistance in cancer therapy

   • Jennifer S. Carew
   • Kevin R. Kelly
   • Steffan T. Nawrocki

   Review 09 March 2011 Pages: 17 - 27

   

4. The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas

   • Sushma Vemulapalli
   • Alain Mita
   • Monica Mita

   Review 28 April 2011 Pages: 29 - 39

   

5. Aging and cancer: can mTOR inhibitors kill two birds with one drug?

   • Zelton Dave Sharp
   • Arlan Richardson

   Review 11 March 2011 Pages: 41 - 51

   

6. Mammalian target of rapamycin as a target in hematological malignancies

   • Kevin R. Kelly
   • Julie H. Rowe
   • Jennifer S. Carew

   Review 17 April 2011 Pages: 53 - 61